Error message

The page you requested does not exist. For your convenience, a search was performed using the query cbssm med umich edu people christian vercler md ma.

Page not found

You are here

Mon, April 24, 2017

Kayte Spector-Bagdady, Ed Goldman, Andrew Shuman and others have recently published a perspective piece in the Journal of Clinical Oncology, "Immortal Life of the Common Rule: Ethics, Consent, and the Future of Cancer Research" which has been highlighted in Michigan Health Lab.

Fri, September 15, 2017

A study on surgeon influence on double mastectomy co-authored by Sarah Hawley and Reshma Jagsi was recently highlighted in Time Health.  This study found that attending surgeons exerted a substantial amount of influence on the likelihood of receipt of contralateral prophylactic mastectomy after a breast cancer diagnosis. Steven Katz was first author of this study.

Funded by Agency for Health Care Research and Quality.

Funding years 2010-2013.

We propose to develop and evaluate in a randomized controlled trial a computer tailored intervention to assist community health workers (CHWs) or other outreach workers to provide personalized patient education materials on oral anti-hyperglycemic medications and insulin to low-literacy, diabetic African American and English and Spanish-speaking Latino adults with poor glycemic control. For more information, visit NIH Reporter

PI(s): Mary Heisler

Co-I(s): Michael Spencer, Melissa Valerio, Caroline Richardson, Angela Fagerlin, Lawrence An, Ananda Sen

 

 

Funded by Brigham and Women's Hospital/Boston Univerity/NIH.

Funding Years: 2010-2013. 

In this continuation of the REVEAL Study, we will conduct a new randomized clinical trial to determine the psychological and health behavior changes associated with disclosing APOE genotype and 3-year Risk estimates to persons with mild memory problems. We will also create a new instrument that clinicians and researchers can use to reliably evaluate a patient's capacity to consent to genetic testing and examine long-term impact of genetic Risk assessment by following REVEAL Study patients 2-10 years following disclosure. For more information, visit NIH Reporter Link

PI(s): J. Scott Roberts 

Funded by Department of Veterans Affairs

Funding Year: 2012

Successful diabetes management is dependent on the patient - provider partnership. However, a full discussion of potential benefits, harms, costs, and burdens associated with each medication option is often too much for a brief clinic visit. This project uses AHRQ-developed consumer guides as inspiration for a tailored program that assists with this decision-making. The current iDECIDE intervention serves as the base of the program, with updates geared toward making it more specific to veterans.

Aim 1: Update current iDECIDE program to make it more appropriate for the VA setting. 

Angela Fagerlin (PI)

Center for Health Communications Research (CHCR) Project

 

Gina Bravo, PhD

Alumni

Gina Bravo was a Visiting Scholar at CBSSM, 2011-2012. She has a PhD in mathematics and post-doctoral training in clinical epidemiology. Professor of Public Health at the University of Sherbrooke since 1991, she teaches research methods and biostatistics to MSc and PhD candidates. She is a member of the Research Centre on Aging located within the University Institute of Geriatrics of Sherbrooke. She has received personal research awards and peer-reviewed grants from the Quebec Health Research funding agency and the Canadian Institutes of Health Research.

Last Name: 
Bravo

Funded by the American Cancer Society

Funding Years: 2006-2011

This study examines the impact of "status-assessing" email messages sent to individuals who decided to quit smoking and chose a date to quit. Participants receive email messages 3 and 5 weeks after their self selected quit dates, asking them to click on a URL link that matches their current smoking status (quit, tried but relapsed, never quit). Participants who click on a link receive information targeted to their current smoking status.

CHCR Link

PI: Brian Zikmund-Fisher, PhD

Funded by the National Institutes of Health

Funding years: 2008-2013

The specific aims are: 1) To test the effectiveness of a preference-tailored (PT) vs. standard information (SI) intervention for increasing primary care patient's CRC screening adherence in a randomized controlled trial at two locations; 2) To assess the impact of the intervention on informed decision making, knowledge and attitudes toward screening, decisional outcomes, and intention to get screened; and 3) To conduct a cost effectiveness analysis of the PT intervention for increasing CRC screening. For more information, visit NIH Reporter

PI: Sarah Hawley

Co-Is: Angela Fagerlin, Victor Strecher

Megan Knaus, MPH

Research Associate

Megan joined CBSSM in winter of 2014 and works with Drs. Fagerlin and Kullgren on several grant funded research projects related to patient decision making and health communication, as well as a pilot study on workplace health promotion and diabetes prevention.

Megan received her BS in Human Biology and Bioethics from Michigan State University and her MPH in Health Behavior and Health Education from the University of Michigan. Her interests are in physician-patient communication, risk communication, and the use of decision aids at the point of care.

Last Name: 
Knaus

CBSSM's Co-Director Angela Fagerlin, Ph.D., has been named one of "25 Champions of Shared Decision Making." According to the Informed Medical Decisions Foundation, "Angie has spent her career testing methods for communicating the risks and benefits of treatment options to patients, especially through decision aids. Based on the knowledge she has gained, Angie developed and tested decision aids for prostate cancer and breast cancer prevention. Her work has truly advanced the field of risk communication and patient-physician communication." 

Congratulations Angie! You can view the list here

Pages